Fidanacogene Elaparvovec

FDA Accepts Pfizer’s Application for Hemophilia B Gene Therapy Fidanacogene Elaparvovec

Source – Pfizer On 28 June 2023, Pfizer announced  that the US Food and Drug Administration (FDA) and the European ...